- Home
- CRBU vs COLA Comparison
CRBU vs COLA Comparison
Compare CRBU & COLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- COLA
- Stock Information
- Founded
- CRBU 2011
- COLA 2024
- Country
- CRBU United States
- COLA Singapore
- Employees
- CRBU N/A
- COLA N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- COLA
- Sector
- CRBU Health Care
- COLA
- Exchange
- CRBU Nasdaq
- COLA NYSE
- Market Cap
- CRBU 93.0M
- COLA 79.8M
- IPO Year
- CRBU 2021
- COLA 2025
- Fundamental
- Price
- CRBU $0.77
- COLA $10.10
- Analyst Decision
- CRBU Strong Buy
- COLA
- Analyst Count
- CRBU 5
- COLA 0
- Target Price
- CRBU $10.60
- COLA N/A
- AVG Volume (30 Days)
- CRBU 1.0M
- COLA 50.2K
- Earning Date
- CRBU 05-08-2025
- COLA 01-01-0001
- Dividend Yield
- CRBU N/A
- COLA N/A
- EPS Growth
- CRBU N/A
- COLA N/A
- EPS
- CRBU N/A
- COLA N/A
- Revenue
- CRBU $9,918,000.00
- COLA N/A
- Revenue This Year
- CRBU N/A
- COLA N/A
- Revenue Next Year
- CRBU $163.34
- COLA N/A
- P/E Ratio
- CRBU N/A
- COLA N/A
- Revenue Growth
- CRBU N/A
- COLA N/A
- 52 Week Low
- CRBU $0.66
- COLA $9.95
- 52 Week High
- CRBU $4.21
- COLA $10.10
- Technical
- Relative Strength Index (RSI)
- CRBU 43.66
- COLA N/A
- Support Level
- CRBU $0.73
- COLA N/A
- Resistance Level
- CRBU $0.91
- COLA N/A
- Average True Range (ATR)
- CRBU 0.08
- COLA 0.00
- MACD
- CRBU 0.01
- COLA 0.00
- Stochastic Oscillator
- CRBU 24.34
- COLA 0.00
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About COLA COLUMBUS ACQUISITION CORP
Columbus Acquisition Corp is a blank check company.